Bill Aims To Hike Penalty For Unreported Drug Trial Results

Law360, New York (May 4, 2012, 6:50 PM EDT) -- A Republican congressman unveiled a bill Thursday he said would boost the low reporting rates of clinical drug trial results by threatening to revoke federal funding for those who don't comply with reporting requirements.

Although current law requires researchers who perform many clinical trials in the U.S. to publish their results in a public database within a year, the reporting rates are dismal. A study published in the British Medical Journal in January found that results had only been reported in 22 percent of clinical drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.